Addeo, Leo
13  Ergebnisse:
Personensuche X
?
2

Italian survey on cetuximab-based therapy of elderly patien..:

Rosati, Gerardo ; Addeo, Raffaele ; Aprile, Giuseppe...
Cancer Chemotherapy and Pharmacology.  84 (2019)  5 - p. 1089-1096 , 2019
 
?
4

Value of contrast‐enhanced 18F‐fluorodeoxyglucose positron ..:

Buchs, Nicolas C ; Bühler, Leo ; Bucher, Pascal...
Journal of Gastroenterology and Hepatology.  26 (2011)  4 - p. 657-662 , 2011
 
?
7

Metronomic oral Vinorelbine and Temozolomide, after whole b..:

Montella, Liliana ; Addeo, Raffaele ; Leo, Gino...
European Journal of Cancer Supplements.  6 (2008)  14 - p. 116 , 2008
 
?
8

Sorafenib plus long-acting octreotide in advanced hepatocel..:

Del Prete, S. ; Addeo, R. ; Maiorino, L....
European Journal of Cancer Supplements.  6 (2008)  14 - p. 119-120 , 2008
 
?
9

Metronomic oral vinorelbine and temozolomide, after whole b..:

Addeo, R. ; Montella, L. ; Leo, G....
European Journal of Cancer Supplements.  6 (2008)  7 - p. 173 , 2008
 
?
11

Beta-erythropoietin in clinical practice: GOIM 2705 multice..:

Addeo, Raffaele ; Cennamo, Gregorio ; Maiorino, Luigi...
European Journal of Cancer Supplements.  6 (2008)  14 - p. 147 , 2008
 
?
12

Bevacizumab+folfiri as first-line treatment in advanced col..:

Giuliani, F. ; Lorusso, V. ; De Vita, F....
European Journal of Cancer Supplements.  6 (2008)  14 - p. 121 , 2008
 
?
13

Sorafenib plus long-acting octreotide in advanced hepatocel..:

A. Vascone ; R. Addeo ; Giovannella Palmieri...
url:https://www.openaccessrepository.it/communities/itmirror.  , 2008
 
1-13